Price T Rowe Associates Inc Penumbra Inc Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Penumbra Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,025,573 shares of PEN stock, worth $580 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

3,025,573

Previous 3,025,823 0.01%

Holding current value

$580 Million

Previous $675 Million 19.37%

% of portfolio

0.07%

Previous 0.08%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$172.27 - $223.95 $43,067 - $55,987	-250 Reduced 0.01%	3,025,573 $545 Million
Q1 2024 May 15, 2024	SELL	$220.09 - $273.15 $17.3 Million - $21.5 Million	-78,767 Reduced 2.54%	3,025,823 $675 Million
Q4 2023 Feb 14, 2024	BUY	$181.44 - $260.22 $207 Million - $297 Million	1,140,807 Added 58.09%	3,104,590 $781 Million
Q3 2023 Nov 14, 2023	SELL	$240.69 - $338.77 $62.9 Million - $88.5 Million	-261,319 Reduced 11.74%	1,963,783 $475 Million
Q2 2023 Aug 14, 2023	BUY	$271.54 - $344.06 $10.9 Million - $13.8 Million	40,040 Added 1.83%	2,225,102 $766 Million
Q1 2023 May 15, 2023	BUY	$220.43 - $278.69 $246 Million - $311 Million	1,115,176 Added 104.23%	2,185,062 $609 Million
Q4 2022 Feb 14, 2023	BUY	$151.88 - $228.5 $6.2 Million - $9.32 Million	40,791 Added 3.96%	1,069,886 $238 Million
Q3 2022 Nov 14, 2022	SELL	$120.36 - $205.88 $24.3 Million - $41.6 Million	-202,034 Reduced 16.41%	1,029,095 $195 Million
Q2 2022 Aug 15, 2022	BUY	$116.09 - $227.33 $10.5 Million - $20.6 Million	90,749 Added 7.96%	1,231,129 $153 Million
Q1 2022 May 16, 2022	SELL	$187.51 - $283.98 $18.4 Million - $27.9 Million	-98,329 Reduced 7.94%	1,140,380 $253 Million
Q4 2021 Feb 14, 2022	BUY	$238.08 - $288.0 $2.71 Million - $3.28 Million	11,389 Added 0.93%	1,238,709 $356 Million
Q3 2021 Nov 15, 2021	SELL	$250.72 - $291.24 $6.99 Million - $8.12 Million	-27,876 Reduced 2.22%	1,227,320 $327 Million
Q2 2021 Aug 16, 2021	SELL	$235.0 - $310.7 $8.04 Million - $10.6 Million	-34,217 Reduced 2.65%	1,255,196 $344 Million
Q1 2021 May 17, 2021	SELL	$175.6 - $291.43 $15.8 Million - $26.2 Million	-89,999 Reduced 6.52%	1,289,413 $349 Million
Q4 2020 Feb 16, 2021	BUY	$174.98 - $272.83 $241 Million - $376 Million	1,379,412 New	1,379,412 $241 Million

Others Institutions Holding PEN

# of Institutions

383

Shares Held

29.6M

Call Options Held

285K

Put Options Held

168K

View Full List

About Penumbra Inc

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $7.26B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

More about PEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Penumbra Inc Transaction History